Anavex Life Sciences Insider Trades
NASDAQ: AVXLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Anavex Life Sciences insider activity
No Anavex Life Sciences insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows MISSLING CHRISTOPHER U (President and CEO) reporting a transaction in 187,500 shares at $5.04 on Sep 11, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AVXL's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AVXL insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 11, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Tax withholding | 145,048 | $1.39M | Form 4 |
| Sep 11, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Option exercise | 187,500 | $945.00K | Form 4 |
| Jun 5, 2025 | Thomas SteffenDirector | Tax withholding | 11,349 | $87.95K | Form 4 |
| Jun 5, 2025 | Thomas SteffenDirector | Option exercise | 50,000 | $88.00K | Form 4 |
| Mar 24, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Tax withholding | 282,497 | $2.72M | Form 4 |
| Mar 24, 2025 | MISSLING CHRISTOPHER UPresident and CEO | Option exercise | 500,000 | $460.00K | Form 4 |
| Jun 14, 2024 | Donhauser Peter D.O.Director | Buy | 2,835 | $10.32K | Form 4 |
| May 15, 2024 | Thomas SteffenDirector | Buy | 5,000 | $22.60K | Form 4 |
| Mar 28, 2024 | MISSLING CHRISTOPHER UPresident and CEO | Sale | 73,380 | $374.97K | Form 4 |
| Mar 28, 2024 | MISSLING CHRISTOPHER UPresident and CEO | Option exercise | 73,380 | $96.86K | Form 4 |
| Jun 29, 2023 | MISSLING CHRISTOPHER UPresident and CEO | Option exercise | 232,000 | $371.20K | Form 4 |
| Jun 28, 2023 | MISSLING CHRISTOPHER UPresident and CEO | Sale | 268,000 | $2.14M | Form 4 |
| Jun 28, 2023 | MISSLING CHRISTOPHER UPresident and CEO | Option exercise | 268,000 | $428.80K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4